Aemetis (AMTX) Competitors $1.43 -0.01 (-0.69%) Closing price 04:00 PM EasternExtended Trading$1.44 +0.02 (+1.05%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMTX vs. ASPI, LXFR, SLI, ARQ, VGAS, TSE, ADUR, ZTEK, ORGN, and BLGOShould you be buying Aemetis stock or one of its competitors? The main competitors of Aemetis include ASP Isotopes (ASPI), Luxfer (LXFR), Standard Lithium (SLI), ARQ (ARQ), Verde Clean Fuels (VGAS), Trinseo (TSE), Aduro Clean Technologies (ADUR), Zentek (ZTEK), Origin Materials (ORGN), and BioLargo (BLGO). These companies are all part of the "chemicals" industry. Aemetis vs. ASP Isotopes Luxfer Standard Lithium ARQ Verde Clean Fuels Trinseo Aduro Clean Technologies Zentek Origin Materials BioLargo ASP Isotopes (NASDAQ:ASPI) and Aemetis (NASDAQ:AMTX) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Is ASPI or AMTX more profitable? Aemetis has a net margin of -33.21% compared to ASP Isotopes' net margin of -807.39%. Aemetis' return on equity of 0.00% beat ASP Isotopes' return on equity.Company Net Margins Return on Equity Return on Assets ASP Isotopes-807.39% -123.83% -51.58% Aemetis -33.21%N/A -40.11% Which has higher valuation and earnings, ASPI or AMTX? ASP Isotopes has higher earnings, but lower revenue than Aemetis. ASP Isotopes is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASP Isotopes$4.14M99.47-$16.29M-$0.61-9.38Aemetis$267.64M0.28-$46.42M-$1.98-0.72 Which has more risk and volatility, ASPI or AMTX? ASP Isotopes has a beta of 3.44, indicating that its stock price is 244% more volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Do institutionals & insiders hold more shares of ASPI or AMTX? 16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 21.4% of ASP Isotopes shares are held by company insiders. Comparatively, 15.9% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer ASPI or AMTX? Aemetis received 174 more outperform votes than ASP Isotopes when rated by MarketBeat users. However, 100.00% of users gave ASP Isotopes an outperform vote while only 59.74% of users gave Aemetis an outperform vote. CompanyUnderperformOutperformASP IsotopesOutperform Votes7100.00% Underperform VotesNo VotesAemetisOutperform Votes18159.74% Underperform Votes12240.26% Do analysts prefer ASPI or AMTX? ASP Isotopes currently has a consensus target price of $4.50, indicating a potential downside of 21.33%. Aemetis has a consensus target price of $14.56, indicating a potential upside of 918.36%. Given Aemetis' higher possible upside, analysts clearly believe Aemetis is more favorable than ASP Isotopes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASP Isotopes 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aemetis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media favor ASPI or AMTX? In the previous week, ASP Isotopes and ASP Isotopes both had 3 articles in the media. ASP Isotopes' average media sentiment score of 0.90 beat Aemetis' score of 0.60 indicating that ASP Isotopes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aemetis 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryASP Isotopes and Aemetis tied by winning 8 of the 16 factors compared between the two stocks. Remove Ads Get Aemetis News Delivered to You Automatically Sign up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMTX vs. The Competition Export to ExcelMetricAemetisIndustrial organic chemicals IndustryEnergy SectorNASDAQ ExchangeMarket Cap$76.25M$2.08B$6.78B$7.57BDividend YieldN/A4.29%11.08%4.32%P/E Ratio-0.6315.6542.6617.81Price / Sales0.2812.0519,957.4094.60Price / CashN/A23.6235.3834.64Price / Book-0.261.273.334.00Net Income-$46.42M-$13.51M$4.27B$247.23M7 Day Performance-14.88%7.68%4.14%7.26%1 Month Performance-14.88%-12.97%-7.62%-6.26%1 Year Performance-64.95%-32.11%141.10%-0.18% Aemetis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMTXAemetis1.6292 of 5 stars$1.43-0.7%$14.56+918.4%-66.4%$76.25M$267.64M-0.63160ASPIASP Isotopes0.7291 of 5 stars$4.57+3.6%$4.50-1.5%+99.7%$329.35M$4.14M-7.4976Gap UpLXFRLuxfer1.8359 of 5 stars$9.98-0.9%N/A+1.4%$266.83M$391.90M30.241,400Dividend AnnouncementSLIStandard Lithium1.961 of 5 stars$1.18-0.8%$3.95+234.7%N/A$228.85MN/A2.00N/AARQARQ2.9003 of 5 stars$3.67-1.1%$9.50+158.9%-51.2%$154.19M$108.96M-367.00140Gap DownVGASVerde Clean Fuels0.2754 of 5 stars$3.12+4.7%N/A-21.7%$139.00MN/A-6.242Gap DownTSETrinseo1.1431 of 5 stars$3.22+1.7%N/A+14.2%$114.07M$3.51B-0.333,400News CoveragePositive NewsADURAduro Clean TechnologiesN/A$3.85-8.8%$50.00+1,198.7%N/A$109.49M$299,021.000.00N/ANews CoverageGap DownHigh Trading VolumeZTEKZentek0.2812 of 5 stars$1.00-3.4%N/A-3.4%$104.39M$64,656.00-14.2924Short Interest ↑News CoverageGap DownORGNOrigin Materials2.3537 of 5 stars$0.57-4.6%$1.50+164.0%+2.3%$84.85M$31.28M-1.00160Short Interest ↓News CoverageBLGOBioLargoN/A$0.24-4.5%N/A-27.0%$72.33M$12.23M-24.0030Gap Up Remove Ads Related Companies and Tools Related Companies ASPI Competitors LXFR Competitors SLI Competitors ARQ Competitors VGAS Competitors TSE Competitors ADUR Competitors ZTEK Competitors ORGN Competitors BLGO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMTX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aemetis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.